Business Description
HCA Healthcare Inc
NAICS : 622110
SIC : 8062
Compare
Compare
Traded in other countries / regions
H1CA34.Brazil2BH.GermanyHCA.Mexico0J1R.UKHCA.USA Description
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -0.05 | |||||
| Debt-to-Equity | -14.4 | |||||
| Debt-to-EBITDA | 3 | |||||
| Interest Coverage | 5.19 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.73 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.5 | |||||
| 3-Year EBITDA Growth Rate | 17.6 | |||||
| 3-Year EPS without NRI Growth Rate | 23.9 | |||||
| 3-Year FCF Growth Rate | 12.3 | |||||
| 3-Year Book Growth Rate | -5.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 10.85 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.88 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.66 | |||||
| 9-Day RSI | 61.78 | |||||
| 14-Day RSI | 59.56 | |||||
| 6-1 Month Momentum % | 7.44 | |||||
| 12-1 Month Momentum % | 4.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.38 | |||||
| Quick Ratio | 1.17 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 78.75 | |||||
| Days Sales Outstanding | 51.73 | |||||
| Days Payable | 157.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.89 | |||||
| Dividend Payout Ratio | 0.12 | |||||
| 3-Year Dividend Growth Rate | 11.9 | |||||
| Forward Dividend Yield % | 0.92 | |||||
| 5-Year Yield-on-Cost % | 0.89 | |||||
| 3-Year Average Share Buyback Ratio | 5.8 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.44 | |||||
| Operating Margin % | 15.03 | |||||
| Net Margin % | 9.37 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 10.92 | |||||
| ROIC % | 17.45 | |||||
| ROC (Joel Greenblatt) % | 34.14 | |||||
| ROCE % | 24.61 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.6 | |||||
| Forward PE Ratio | 15.17 | |||||
| PE Ratio without NRI | 13.6 | |||||
| Shiller PE Ratio | 23.44 | |||||
| Price-to-Owner-Earnings | 15.58 | |||||
| PEG Ratio | 0.87 | |||||
| PS Ratio | 1.28 | |||||
| Price-to-Free-Cash-Flow | 18.46 | |||||
| Price-to-Operating-Cash-Flow | 8.97 | |||||
| EV-to-EBIT | 10.93 | |||||
| EV-to-Forward-EBIT | 12.49 | |||||
| EV-to-EBITDA | 8.49 | |||||
| EV-to-Forward-EBITDA | 9.32 | |||||
| EV-to-Revenue | 1.87 | |||||
| EV-to-Forward-Revenue | 1.81 | |||||
| EV-to-FCF | 27.34 | |||||
| Price-to-Projected-FCF | 1.29 | |||||
| Price-to-DCF (Earnings Based) | 0.38 | |||||
| Price-to-DCF (FCF Based) | 0.66 | |||||
| Price-to-Median-PS-Value | 1.46 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.89 | |||||
| Earnings Yield (Greenblatt) % | 9.15 | |||||
| Forward Rate of Return (Yacktman) % | 20.36 |
